Grupo 27
Farmacia Hospitalaria y Farmacogenómica
Publicaciones (387)
-
Chamorro-de-Vega, E; Rodriguez-Gonzalez, CG; Manrique-Rodriguez, S; Lobato-Matilla, E; Garcia-Moreno, F; Olmedo, M; Correa-Rocha, R; Valerio, M; Aldamiz-Echevarria, T; Machado, M; Sancho-Gonzalez, M; Lopez-Bernaldo-de-Quiros, JC; Ruiz-Briones, P; Romero-Jimenez, R; Sarobe-Gonzalez, C; Gimenez-Manzorro, A; Collado-Borrell, R; Fernandez-Llamazares, CM; Revuelta-Herrero, JL; Somoza-Fernandez, B; Garcia-Sanchez, S; Taladriz-Sender, I; Bouza, E; Herranz, A; Munoz, P; Sanjurjo, M.
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
Expert Review of Clinical Pharmacology. 2021; 14(2): 249-260 Nº de citas: 6 [doi:10.1080/17512433.2021.1875819]
-
Ruiz-Pinto, S; Pita, G; Martin, M; Nunez-Torres, R; Cuadrado, A; Shahbazi, MN; Caronia, D; Kojic, A; Moreno, LT; de la Torre-Montero, JC; Lozano, M; Lopez-Fernandez, LA; Ribelles, N; Garcia-Saenz, JA; Alba, E; Milne, RL; Losada, A; Perez-Moreno, M; Benitez, J; Gonzalez-Neira, A.
Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome
CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021; 109(2): 462-470 Nº de citas: 5 [doi:10.1002/cpt.2013]
-
Salvador-Martin, S; Pujol-Muncunill, G; Bossacoma, F; Navas-Lopez, VM; Gallego-Fernandez, C; Segarra, O; Clemente, S; Munoz-Codoceo, R; Viada, J; Magallares, L; Martinez-Ojinaga, E; Moreno-Alvarez, A; Solar-Boga, A; Loverdos, I; Merino-Bohorquez, V; Balboa-Vega, MJ; Rodriguez-Martinez, A; Alvarez-Vayo, C; Sanchez, C; Tolin, M; Blanca-Garcia, JA; Garcia-Ronnero, R; Eizaguirre, FJ; Sanchez-Hernandez, JG; de Caldas, RG; Millan-Jinnenez, A; Aznal, E; Abarca-Zabalia, J; Sanjurjo-Saez, M; Lopez-Fernandez, LA.
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021; 87(2): 447-457 Nº de citas: 12 [doi:10.1111/bcp.14400]
-
Amor-Garcia, MA; Ibanez-Garcia, S; Garcia-Gonzalez, X; Mombiela, T; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.
Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study
BMC Pulmonary Medicine. 2021; 21(1): 48-48 Nº de citas: 1 [doi:10.1186/s12890-021-01416-7]
-
Margusino-Framinan, L; Fernandez-Llamazares, CM; Negro-Vega, E; Tortajada-Goitia, B; Lizeaga, G; Mercadal-Orfila, G; Almeida-Gonzalez, C; Morillo-Verdugo, R.
Outpatients' Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project
Journal of Multidisciplinary Healthcare. 2021; 14: 3621-3632 Nº de citas: 8 [doi:10.2147/JMDH.S343528]
-
Machado, M; de Vega, EC; Martinez-Jimenez, MD; Rodriguez-Gonzalez, CG; Vena, A; Navarro, R; Zamora-Cintas, MI; Agnelli, C; Olmedo, M; Galar, A; Guinea, J; Fernandez-Cruz, A; Alonso, R; Bouza, E; Munoz, P; Valerio, M.
Utility of 1,3 beta-d-Glucan Assay for Guidance in Antifungal Stewardship Programs for Oncologic Patients and Solid Organ Transplant Recipients
Journal of Fungi. 2021; 7(1): Nº de citas: 8 [doi:10.3390/jof7010059]
-
Galar, A; Valerio, M; Catalan, P; Garcia-Gonzalez, X; Burillo, A; Fernandez-Cruz, A; Zatarain, E; Sousa-Casasnovas, I; Anaya, F; Rodriguez-Ferrero, ML; Munoz, P; Bouza, E.
Valganciclovir-Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
Antibiotics-Basel. 2021; 10(1): Nº de citas: 25 [doi:10.3390/antibiotics10010077]
-
Rubio-Salvador, AR; Escudero-Vilaplana, V; Rodriguez, JAM; Mangues-Bafalluy, I; Bernardez, B; Collado, CG; Collado-Borrell, R; Fernandez, MDA; Lopez-Muniz, JIC; Cortes, MY; Barrera, MG; Calleja-Hernandez, MA.
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study
International Journal of Environmental Research and Public Health. 2021; 18(2): Nº de citas: 6 [doi:10.3390/ijerph18020394]
-
Salvador-Martin, S; Kaczmarczyk, B; Alvarez, R; Navas-Lopez, VM; Gallego-Fernandez, C; Moreno-Alvarez, A; Solar-Boga, A; Sanchez, C; Tolin, M; Velasco, M; Munoz-Codoceo, R; Rodriguez-Martinez, A; Vayo, CA; Bossacoma, F; Pujol-Muncunill, G; Fobelo, MJ; Millan-Jimenez, A; Magallares, L; Eva, O; Loverdos, I; Eizaguirre, FJ; Blanca-Garcia, JA; Clemente, S; Garcia-Romero, R; Merino-Bohorquez, V; de Caldas, RG; Vazquez, E; Dopazo, A; Sanjurjo-Saez, M; Lopez-Fernandez, LA.
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
Pharmaceutics. 2021; 13(1): Nº de citas: 16 [doi:10.3390/pharmaceutics13010077]
-
Butragueno-Laiseca, L; Troconiz, IF; Grau, S; Campillo, N; Garcia, X; Padilla, B; Fernandez, SN; Santiago, MJ.
Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury
Antibiotics-Basel. 2020; 9(12): Nº de citas: 11 [doi:10.3390/antibiotics9120887]
-
Collado-Borrell, R; Escudero-Vilaplana, V; Ribed, A; Gonzalez-Anleo, C; Martin-Conde, M; Romero-Jimenez, R; Iglesias-Peinado, I; Herranz-Alonso, A; Sanjurjo-Saez, M.
Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study
JMIR mHealth and uHealth. 2020; 8(10): Nº de citas: 10 [doi:10.2196/20480]
-
Salvador-Martin, S; Bossacoma, F; Pujol-Muncunill, G; Navas-Lopez, VM; Gallego-Fernandez, C; Viada, J; Muñoz-Codoceo R; Magallares, L; Martinez-Ojinaga, E; Moreno-Alvarez, A; Solar-Boga, A; Segarra, O; Clemente, S; Rodriguez-Martinez, A; Alvarez-Vayo, C; Loverdos, I; Merino-Bohorquez, V; Balboa-Vega, MJ; Blanca-Garcia, JA; Fobelo, MJ; Millan-Jimenez, A; Garcia-Romero, R; Sanchez, C; Tolin, M; Caldas RG; Eizaguirre, FJ; Sanchez-Hernandez, JG; Torres-Peral, R; Aznal, E; Garcia-Gonzalez, X; Sanjurjo-Saez, M; Lopez-Fernandez, LA.
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2020; 71(4): 508-515 Nº de citas: 11 [doi:10.1097/MPG.0000000000002840]
-
Escudero-Vilaplana, V; Calles, A; Collado-Borrell, R; Marzal-Alfaro, MB; Polanco, C; Garrido, C; Suarez, J; Ortiz, A; Appierto, M; Comellas, M; Lizan, L.
Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting
Frontiers in Oncology. 2020; 10: Nº de citas: 8 [doi:10.3389/fonc.2020.01645]
-
Collado-Borrell, R; Escudero-Vilaplana, V; Ribed, A; Jimenez, RR; Peinado, II; Herranz-Alonso, A; Sanjurjo-Saez, M.
Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2020; 77(17): 1393-1402 Nº de citas: 4 [doi:10.1093/ajhp/zxaa144]
-
Gonzalez-Haba-Pena, E; Garrido-Siles, M; Martinez-Bautista, MJ; Burgos-San Jose, A; Aldaz-Pastor, A; Mangues-Bafalluy, I; Spanish Soc Hosp Pharmacists.
Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients
FARMACIA HOSPITALARIA. 2020; 44(5): 192-197 Nº de citas: 2 [doi:10.7399/fh.11402]
-
Marquinez-Alonso, I; Escudero-Vilaplana, V; Osorio, S; Rodriguez-Gonzalez, CG; Gonzalez-Haba, E; Sanjurjo-Saez, M.
Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital
EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2020; 27(5): 299-301 Nº de citas: 2 [doi:10.1136/ejhpharm-2017-001378]
-
Marzal-Alfaro, M; Rodriguez-Gonzalez, CG; Escudero-Vilaplana, V; Revuelta-Herrero, JL; Gonzalez-Haba, E; Ibanez-Garcia, S; Iglesias-Peinado, I; Herranz-Alonso, A; Saez, MS.
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety
Health Informatics Journal. 2020; 26(3): 1995-2010 Nº de citas: 3 [doi:10.1177/1460458219895434]
-
Collado-Borrell, R; Escudero-Vilaplana, V; Villanueva-Bueno, C; Herranz-Alonso, A; Sanjurjo-Saez, M.
Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis
JOURNAL OF MEDICAL INTERNET RESEARCH. 2020; 22(8): Nº de citas: 67 [doi:10.2196/20334]